EVALUATION OF DRUG CANDIDATES FOR PRECLINICAL DEVELOPMENT
Passe o mouse na imagem para ver detalhes Ampliar

EVALUATION OF DRUG CANDIDATES FOR PRECLINICAL DEVELOPMENT

It is believed that selecting the "right" drug candidate for development is the key to success. In the last decade, pharmaceutical R&D departments have integrated pharmacokinetics and drug metabolism, pharmaceutics, and toxicology into early drug discovery to improve the assessment of potential drug compounds. Now, Evaluation of Drug Candidates for Preclinical Development provides a complete view and understanding of why absorption-distribution-metabolism-excretion-toxicology (ADMET) plays a pivotal role in drug discovery and development.Encompassing the three major interrelated areas in which optimization and evaluation of drug developability is most critical--pharmacokinetics and drug metabolism, pharmaceutics, and safety assessment--this unique resource encourages integrated thinking in drug discovery.
Editora: JOHN WILEY
ISBN: 0470044918
ISBN13: 9780470044919
Edição: 1ª Edição - 2010
Número de Páginas: 289
Acabamento: HARDCOVER
por R$ 892,16 4x de R$ 223,04 sem juros